Lifecore Biomedical Aktie
WKN: 899376 / ISIN: US5147661046
31.03.2015 23:53:02
|
Landec Q3 Profit Meets Estimate
(RTTNews) - Landec Corp. (LNDC) reported net income for the third quarter of $3.8 million or $0.14 per share, compared to $6.4 million or $0.24 per share for the year-ago quarter.
Revenues for the third quarter rose 10% to $138.5 million from $126.4 million a year earlier, mainly due to a 21% increase in revenues in Apio's value-added business, which includes its Eat Smart fresh-cut specialty packaged vegetable business, Apio Cooling and Apio Packaging.
Analysts polled by Thomson Reuters expected the company to earn $0.14 per share on revenue of $135.73 million for the third quarter.
Looking forward to the fourth quarter, the company forecasts revenues of $130.0 million to $135.0 million and earnings per share of $0.18 to $0.20. Analysts currently expect the company to earn $0.20 per share on revenue of $127,20 million for the fourth quarter.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Lifecore Biomedicalmehr Nachrichten
04.04.25 |
Zurückhaltung in New York: NASDAQ Composite bricht schlussendlich ein (finanzen.at) | |
04.04.25 |
NASDAQ Composite aktuell: NASDAQ Composite bricht am Nachmittag ein (finanzen.at) | |
04.04.25 |
Schwache Performance in New York: NASDAQ Composite rauscht am Freitagmittag ab (finanzen.at) | |
04.04.25 |
NASDAQ Composite Index-Wert Lifecore Biomedical-Aktie: So viel hätte eine Investition in Lifecore Biomedical von vor 10 Jahren gekostet (finanzen.at) | |
04.04.25 |
Minuszeichen in New York: NASDAQ Composite zum Start des Freitagshandels schwächer (finanzen.at) | |
31.03.25 |
Schwacher Wochentag in New York: NASDAQ Composite zum Handelsende im Minus (finanzen.at) | |
28.03.25 |
NASDAQ Composite Index-Wert Lifecore Biomedical-Aktie: So viel Verlust hätte eine Lifecore Biomedical-Investition von vor 5 Jahren eingebracht (finanzen.at) | |
27.03.25 |
Börse New York in Rot: NASDAQ Composite verbucht Verluste (finanzen.at) |
Analysen zu Lifecore Biomedicalmehr Analysen
Aktien in diesem Artikel
Lifecore Biomedical | 4,74 | -21,65% |
|